Last 7 days
-1.0%
Last 30 days
-4.5%
Last 90 days
-9.4%
Trailing 12 Months
-15.7%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
DHR | 180.7B | 31.5B | -0.78% | -13.30% | 25.07 | 5.74 | 6.85% | 12.06% |
ABT | 171.9B | 43.7B | -4.52% | -15.68% | 24.79 | 3.94 | 1.34% | -1.95% |
MDT | 105.6B | 30.8B | -6.73% | -24.80% | 25.98 | 3.43 | -3.19% | -17.38% |
ISRG | 89.7B | 6.2B | 9.79% | -8.77% | 67.87 | 14.42 | 8.97% | -22.43% |
IDXX | 40.2B | 3.4B | 1.94% | -10.16% | 59.26 | 11.95 | 4.73% | -8.83% |
MID-CAP | ||||||||
PEN | 10.5B | 847.1M | 5.10% | 33.54% | -5.2K | 12.36 | 13.32% | -137.89% |
NEOG | 3.9B | 630.7M | -5.79% | -41.33% | -242.52 | 6.24 | 25.40% | -128.45% |
QDEL | 3.7B | - | -3.05% | -21.16% | 3.27 | 1.42 | - | - |
SMALL-CAP | ||||||||
CYRX | 1.1B | 237.3M | 15.32% | -32.47% | -24.23 | 4.63 | 6.59% | 84.02% |
HSKA | 958.4M | 257.3M | 13.67% | -32.65% | -48.19 | 3.72 | 1.41% | -1632.49% |
APEN | 412.1M | 71.7M | -0.40% | 60.36% | -10.13 | 5.75 | 20.17% | -128.83% |
SRDX | 260.1M | 101.9M | -22.22% | -55.97% | -8.05 | 2.55 | -3.74% | -420.65% |
DARE | 85.6M | - | -4.67% | -35.44% | -3.49 | 801.64 | 4.35% | 34.71% |
XTNT | 75.1M | 58.0M | -14.05% | 3.76% | -8.85 | 1.3 | 4.90% | -74.98% |
ZSAN | 2.7M | - | -66.21% | -40.16% | -0.05 | 4.15 | - | - |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | -3.1% | 43,653 | 45,030 | 45,548 | 44,514 | 43,075 |
S&GA Expenses | -0.7% | 11,248 | 11,323 | 11,359 | 11,328 | 11,324 |
R&D Expenses | -1.3% | 2,888 | 2,925 | 2,815 | 2,785 | 2,742 |
Costs and Expenses | -0.9% | 35,291 | 35,594 | 35,336 | 35,286 | 34,650 |
EBITDA | -9.3% | 10,118 | 11,160 | 11,897 | 10,950 | - |
EBITDA Margin | -6.5% | 0.23* | 0.25* | 0.26* | 0.25* | - |
Earnings Before Taxes | -10.8% | 8,306 | 9,313 | 10,048 | 9,044 | 8,211 |
EBT Margin | -8.0% | 0.19* | 0.21* | 0.22* | 0.20* | - |
Interest Expenses | 4.3% | 558 | 535 | 527 | 529 | 533 |
Net Income | -12.1% | 6,933 | 7,889 | 8,554 | 7,725 | 7,071 |
Net Income Margin | -9.3% | 0.16* | 0.18* | 0.19* | 0.17* | - |
Free Cahsflow | -8.6% | 7,804 | 8,541 | 8,468 | 8,152 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | 2.2% | 74,438 | 72,801 | 74,202 | 74,007 | 75,196 |
Current Assets | 1.5% | 25,224 | 24,845 | 24,956 | 23,429 | 24,239 |
Cash Equivalents | 3.0% | 9,882 | 9,594 | 8,937 | 7,675 | 9,799 |
Inventory | 7.7% | 6,173 | 5,734 | 5,899 | 5,691 | 5,157 |
Net PPE | 5.4% | 9,162 | 8,689 | 8,818 | 8,908 | 8,959 |
Goodwill | 2.3% | 22,799 | 22,284 | 22,744 | 23,179 | 23,231 |
Current Liabilities | 15.9% | 15,489 | 13,365 | 12,392 | 12,647 | 13,105 |
. Short Term Borrowings | - | - | - | - | - | - |
Long Term Debt | - | 18,050 | - | - | - | - |
LT Debt, Current | 101.5% | 2,251 | 1,117 | 5.00 | 4.00 | 754 |
LT Debt, Non Current | -5.1% | 14,522 | 15,297 | 16,755 | 17,086 | 17,296 |
Shareholder's Equity | 2.8% | 36,686 | 35,675 | 36,490 | 35,399 | 35,802 |
Retained Earnings | 0.4% | 35,257 | 35,115 | 34,487 | 33,295 | 31,528 |
Accumulated Depreciation | 4.1% | 11,050 | 10,617 | 10,640 | 10,613 | 10,405 |
Shares Outstanding | -0.1% | 1,753 | 1,754 | 1,762 | - | - |
Minority Interest | 4.8% | 219 | 209 | 226 | 230 | 222 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | -7.2% | 9,581 | 10,322 | 10,243 | 9,961 | 10,533 |
Share Based Compensation | 1.3% | 685 | 676 | 667 | 657 | 640 |
Cashflow From Investing | 2.2% | -1,740 | -1,779 | -1,946 | -1,946 | -2,008 |
Cashflow From Financing | 5.3% | -7,636 | -8,065 | -7,899 | -8,350 | -5,494 |
Dividend Payments | 0.8% | 3,309 | 3,284 | 3,259 | 3,234 | 3,202 |
Buy Backs | -7.1% | 3,795 | 4,084 | 3,865 | 4,331 | 2,299 |
36.1%
5%
0%
Y-axis is the maximum loss one would have experienced if Abbott Laboratories was unfortunately bought at previous high price.
13.1%
15.4%
12.2%
13.7%
FIve years rolling returns for Abbott Laboratories.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-15 | B. Riley Wealth Advisors, Inc. | reduced | -2.48 | 626,133 | 6,465,130 | 0.18% |
2023-03-13 | Claro Advisors LLC | added | 35.55 | 158,798 | 589,798 | 0.19% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | reduced | -3.34 | 7,272,550 | 82,384,600 | 0.09% |
2023-03-10 | MATHER GROUP, LLC. | added | 14.43 | 768,634 | 3,344,630 | 0.06% |
2023-03-08 | Pacific Wealth Management | reduced | -2.34 | 451,513 | 4,625,510 | 3.40% |
2023-03-08 | Capital Asset Advisory Services LLC | added | 21.93 | 458,625 | 1,619,620 | 0.13% |
2023-03-08 | SHEETS SMITH WEALTH MANAGEMENT | reduced | -9.42 | 11,078 | 396,078 | 0.06% |
2023-03-07 | Great Lakes Retirement, Inc. | new | - | 1,099,960 | 1,099,960 | 0.28% |
2023-03-06 | BIRMINGHAM CAPITAL MANAGEMENT CO INC/AL | unchanged | - | 334,407 | 2,819,410 | 1.07% |
2023-03-06 | NORTH STAR ASSET MANAGEMENT INC | added | 0.87 | 3,623,700 | 28,696,700 | 1.78% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 09, 2023 | vanguard group inc | 8.92% | 155,480,794 | SC 13G/A | |
Feb 06, 2023 | blackrock inc. | 8.0% | 139,526,216 | SC 13G/A | |
Feb 09, 2022 | vanguard group inc | 8.43% | 149,152,264 | SC 13G/A | |
Feb 01, 2022 | blackrock inc. | 7.8% | 137,155,602 | SC 13G/A | |
Feb 16, 2021 | capital research global investors | 4.9% | 86,394,199 | SC 13G/A | |
Feb 10, 2021 | vanguard group inc | 8.31% | 147,272,920 | SC 13G/A | |
Jan 29, 2021 | blackrock inc. | 7.5% | 133,426,810 | SC 13G/A | |
Feb 14, 2020 | capital research global investors | 6.4% | 113,689,293 | SC 13G/A | |
Feb 12, 2020 | vanguard group inc | 8.58% | 151,783,436 | SC 13G/A | |
Feb 05, 2020 | blackrock inc. | 7.1% | 124,728,602 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | - - | - - | - - | - - | - - |
Current Inflation | 70.76 -27.83% | 90.64 -7.56% | 126.76 29.28% | 177.83 81.37% | 202.41 106.44% |
Very High Inflation | - - | - - | - - | - - | - - |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 17, 2023 | ARS | ARS | |
Mar 17, 2023 | DEF 14A | DEF 14A | |
Mar 17, 2023 | DEFA14A | DEFA14A | |
Mar 02, 2023 | 4 | Insider Trading | |
Mar 02, 2023 | 4 | Insider Trading | |
Mar 02, 2023 | 4 | Insider Trading | |
Mar 02, 2023 | 4 | Insider Trading | |
Mar 02, 2023 | 4 | Insider Trading | |
Mar 02, 2023 | 4 | Insider Trading | |
Mar 02, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-01 | Ahlberg Gregory A | sold | -132,622 | 100 | -1,317 | senior vice president |
2023-03-01 | Ginascol John F | sold | -94,960 | 100 | -943 | executive vice president |
2023-03-01 | DALE MICHAEL D | sold | -121,746 | 100 | -1,209 | senior vice president |
2023-03-01 | WOODGRIFT RANDEL WILLIAM | sold | -103,922 | 100 | -1,032 | senior vice president |
2023-03-01 | MANNING JOSEPH J | sold | -134,837 | 100 | -1,339 | executive vice president |
2023-03-01 | Salvadori Daniel Gesua Sive | sold | -109,260 | 100 | -1,085 | executive vice president |
2023-03-01 | Tyler Julie L. | sold | -52,867 | 100 | -525 | senior vice president |
2023-03-01 | Moreland Mary K | sold | -72,252 | 100 | -717 | executive vice president |
2023-03-01 | Funck, Jr. Robert E. | sold | -127,285 | 100 | -1,264 | executive vice president |
2023-03-01 | Earnhardt Lisa D | sold | -94,960 | 100 | -943 | executive vice president |
Consolidated Statement of Earnings - USD ($) shares in Millions, $ in Millions | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Statement [Abstract] | |||
Net Sales | $ 43,653 | $ 43,075 | $ 34,608 |
Cost of products sold, excluding amortization of intangible assets | 19,142 | 18,537 | 15,003 |
Amortization of intangible assets | 2,013 | 2,047 | 2,132 |
Research and development | 2,888 | 2,742 | 2,420 |
Selling, general and administrative | 11,248 | 11,324 | 9,696 |
Total Operating Cost and Expenses | 35,291 | 34,650 | 29,251 |
Operating Earnings | 8,362 | 8,425 | 5,357 |
Interest expense | 558 | 533 | 546 |
Interest income | (183) | (43) | (46) |
Net foreign exchange (gain) loss | 2 | 1 | (8) |
Other (income) expense, net | (321) | (277) | (103) |
Earnings from Continuing Operations Before Taxes | 8,306 | 8,211 | 4,968 |
Taxes on Earnings from Continuing Operations | 1,373 | 1,140 | 497 |
Earnings from Continuing Operations | 6,933 | 7,071 | 4,471 |
Net Earnings from Discontinued Operations, net of taxes | 0 | 0 | 24 |
Net Earnings | $ 6,933 | $ 7,071 | $ 4,495 |
Basic Earnings Per Common Share -- | |||
Continuing Operations (in dollars per share) | $ 3.94 | $ 3.97 | $ 2.51 |
Discontinued Operations (in dollars per share) | 0 | 0 | 0.01 |
Net Earnings (in dollars per share) | 3.94 | 3.97 | 2.52 |
Diluted Earnings Per Common Share -- | |||
Continuing Operations (in dollars per share) | 3.91 | 3.94 | 2.49 |
Discontinued Operations (in dollars per share) | 0 | 0 | 0.01 |
Net Earnings (in dollars per share) | $ 3.91 | $ 3.94 | $ 2.50 |
Average Number of Common Shares Outstanding Used for Basic Earnings Per Common Share (in shares) | 1,753 | 1,775 | 1,773 |
Dilutive Common Stock Options (in shares) | 11 | 14 | 13 |
Average Number of Common Shares Outstanding Plus Dilutive Common Stock Options (in shares) | 1,764 | 1,789 | 1,786 |
Outstanding Common Stock Options Having No Dilutive Effect (in shares) | 3 | 0 | 9 |
Consolidated Balance Sheet - USD ($) $ in Millions | Dec. 31, 2022 | Dec. 31, 2021 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 9,882 | $ 9,799 |
Investments, primarily bank time deposits and U.S. treasury bills | 288 | 450 |
Trade receivables, less allowances of — 2022: $500; 2021: $519 | 6,218 | 6,487 |
Inventories: | ||
Finished products | 3,805 | 3,081 |
Work in process | 680 | 694 |
Materials | 1,688 | 1,382 |
Total inventories | 6,173 | 5,157 |
Other prepaid expenses and receivables | 2,663 | 2,346 |
Total current assets | 25,224 | 24,239 |
Investments | 766 | 816 |
Property and equipment, at cost: | ||
Land | 511 | 525 |
Buildings | 4,053 | 4,007 |
Equipment | 14,164 | 13,528 |
Construction in progress | 1,484 | 1,304 |
Property and equipment, at cost | 20,212 | 19,364 |
Less: accumulated depreciation and amortization | 11,050 | 10,405 |
Net property and equipment | 9,162 | 8,959 |
Intangible assets, net of amortization | 10,454 | 12,739 |
Goodwill | 22,799 | 23,231 |
Deferred income taxes and other assets | 6,033 | 5,212 |
Total Assets | 74,438 | 75,196 |
Current liabilities: | ||
Trade accounts payable | 4,607 | 4,408 |
Salaries, wages and commissions | 1,556 | 1,625 |
Other accrued liabilities | 5,845 | 5,181 |
Dividends payable | 887 | 831 |
Income taxes payable | 343 | 306 |
Current portion of long-term debt | 2,251 | 754 |
Total current liabilities | 15,489 | 13,105 |
Long-term debt | 14,522 | 17,296 |
Post-employment obligations and other long-term liabilities | 7,522 | 8,771 |
Commitments and contingencies | ||
Shareholders’ investment: | ||
Preferred shares, one dollar par value Authorized — 1,000,000 shares, none issued | 0 | 0 |
Common shares, without par value Authorized — 2,400,000,000 shares Issued at stated capital amount — Shares: 2022: 1,986,519,278; 2021: 1,985,273,421 | 24,709 | 24,470 |
Common shares held in treasury, at cost — Shares: 2022: 248,724,257; 2021: 221,191,228 | (15,229) | (11,822) |
Earnings employed in the business | 35,257 | 31,528 |
Accumulated other comprehensive income (loss) | (8,051) | (8,374) |
Total Abbott Shareholders’ Investment | 36,686 | 35,802 |
Noncontrolling interests in subsidiaries | 219 | 222 |
Total Shareholders’ Investment | 36,905 | 36,024 |
Total Liabilities and Shareholders' Investment | $ 74,438 | $ 75,196 |